Turn back the clock with the revolutionary new skin treatment

Working differently to fillers SuneKOS stimulates your own collagen and elastin to restore your natural beauty. Improve wrinkles and the signs of ageing and be the new you with this scientifically proven game changing new treatment.

How it works

SuneKOS injectable treatment stimulates the production of new collagen and elastin, to help rebuild and rejuvenate your skin. Our unique formula of two essential ingredients Hyaluronic Acid and Amino Acids stimulate collagen and elastin fibres, enabling cellular matrix regeneration (ECM).

Sunekos 1200

Sagging skin and severe wrinkles are mainly caused by loss of volume. HA over 1 Mio Dalton protects fibroblasts and structural elements of the dermis, as a Free Radical "Scavenger". It has antioxidant and "volumising" properties, boosting the consequent action of Performa. 

This treatment can be used to treat:

• Lower face 
• Hands

The SuneKOS ® 1200 product is characterized by the presence, as the name says, of a higher molecular weight hyaluronic acid and that allows us to create volume that is needed, called “cushion”, and boosts the rejuvenation process when used as a base for SuneKOS ® Performa. 

1 treatment of 1200, combined with Performa in the first session.

SuneKOS Body

SuneKOS ® Body is an injectable indicated for the treatment of stretchmarks (striae distensae) and skin laxity. 

This versatile treatment can be used to treat:

• Arms
• Abdomen
• Knees
• Inner thighs 

It contains the HY6AA Formula but with a different mix adapted to treat the skin laxity of arms, inner thigh, knees and abdomen. In particular, it has changed the type and concentration of the Hyaluronic Acid (low density), and also its ratio vs AA. This is to adapt to the different behaviour of these parts of the body that have different density and are mainly affected by skin laxity

3-4 sessions placed 14-21 days apart.

SuneKOS Cell

SuneKOS ® CELL is a resorbable, sterile, injectable solution that promotes the recovery of physiological conditions, affected by inflammatory and structural factors, on the microcirculation and interstitial level. 

The device acts as a tissue lubricant in edematous fibrosclerotic panniculopathies (PEFs), the primary cause of which is determined by abnormalities of the vessel-tissue exchange with an abnormal increase in the permeability of the capillary-venular endothelial which causes plasmatic exudation and, therefore, interstitial.

Today, numerous pathophysiological considerations demonstrate the need to intervene also and especially on the extracellular matrix.

The synergy of the mix of HA + AA and an Alkaline Solution determines the physiological induction of the precise mechanisms to improve the structure of the ECM, adjusting micro circulation and reducing fibrosis.

3-4 sessions placed 14-21 days apart.

Sunekos Cell acts by:

• The optimization of the ECM protein turnover: neo-collagenases and not collagenase (HA + AA)
• Improvement of the micro-circulation
• Re-equilibrium of the ECM inflammation reducing fibrosis